In-vitro activity of RP 59500, a new semisynthetic injectable pristinamycin against staphylococci

Zentralblatt fur Bakteriologie

Volumn 283, Issue 4, 1996, Pages 497-501

  Von Eiff, Christof ^a   Peters, Georg ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; QUINUPRISTIN-DALFOPRISTIN; VIRGINIAMYCIN;

ARTICLE; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; PENICILLIN RESISTANCE; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS; VIRGINIAMYCIN;

EID: 0030115851     PISSN: 09348840     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0934-8840(96)80127-7     Document Type: Article

References (15)

1. Andrews, J. M. and R. Wise: The in-vitro activity of a new semi-synthetic streptogramin compound, RP 59500, against staphylococci and respiratory pathogens. J. Antimicrob. Chemother. 33 (1994) 849-853
2. Barriere, J. C., D. H. Bouanchaud, J. M. Paris, O. Rolin, N. V. Harris, and C. Smith: Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds. J. Antimicrob. Chemother. 30 Suppl A (1992) 1-8
3. Brumfitt, W., J. M. Hamilton Miller, and S. Shah: In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria. J. Antimicrob. Chemother. 30 Suppl A (1992) 29-37
4. Fantin, B., R. Leclercq, Y. Merle, L. Saint Julien, C. Veyrat, J. Duval, and C. Carbon: Critical influence of resistance to streptogramin B-type antibiotics on activity of RJP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus. Antimicrob. Agents Chemother. 39 (1995) 400-405
5. Fass, R. J.: In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci. Antimicrob. Agents Chemother. 35 (1991) 553-559
6. Hoban, D. J., B. Weshnoweski, L. Palatnick, C. G. Zhanel, and R. J. Davidson: In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies. J. Antimicrob. Chemother. 30 Suppl A (1992) 59-65
7. Inoue, M., R. Okamoto, T. Okubo, K. Inoue, and S. Mitsuhashi: Comparative in-vitro activity of RP 59500 against clinical bacterial isolates. J. Antimicrob. Chemother. 30 Suppl A (1992) 45-51
8. Leclercq, R., L. Nantas, C. J. Soussy, and J. Duval: Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphyloccci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics. J. Antimicrob. Chemother. 30 Suppl A (1992) 67-75
9. Maple, P. A., J. M. Hamilton Miller, and W. Brumfitt: World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet 1 (1989) 537-540
10. Neu, H. C., N. X. Chin, and J. W. Gu: The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination. J. Antimicrob. Chemother. 30 Suppl A (1992) 83-94
11. Noble, W. C., Z. Virani, and R. G. Cree: Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 72 (1992) 195-198
12. Pechere, J. C.: In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci. J. Antimicrob. Chemother. 30 Suppl A (1992) 15-18
13. Sanyal, D., A. P. Johnson, R. C. George, B. D. Cookson, and A. J. Williams: Peritonitis due to vancomycin-resistant Staphylococcus epidermidis [letter]. Lancet 337 (1991) 54
14. Soussy, C. J., J. F. Acar, R. Cluzel, P. Courvalin, J. Duval, J. Fleurette, F. Megraud, M. Meyran, and A. Thabaut: A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France. J. Antimicrob. Chemother. 30 Suppl A (1992) 53-58
15. Voss, A., D. Milatovic, C. Wallrauch Schwarz, V. T. Rosdahl, and I. Braveny: Methicillin-resistant Staphylococcus aureus in Europe. Eur. J. Clin. Microbiot. Infect. Dis. 13 (1994) 50-55